FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome

Wiskott–Aldrich Syndrome, WAS/WAVE, is a rare, X-linked immune-deficiency disease caused by mutations in the WAS gene, which together with its homolog, N-WASP, regulates actin cytoskeleton remodeling and cell motility. WAS patients suffer from microthrombocytopenia, characterized by a diminished num...

Full description

Bibliographic Details
Main Authors: Chunlin Wang, Klarke M. Sample, Babu Gajendran, Philipp Kapranov, Wuling Liu, Anling Hu, Eldad Zacksenhaus, Yanmei Li, Xiaojiang Hao, Yaacov Ben-David
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.607836/full
_version_ 1818926091793858560
author Chunlin Wang
Chunlin Wang
Klarke M. Sample
Babu Gajendran
Babu Gajendran
Philipp Kapranov
Wuling Liu
Wuling Liu
Anling Hu
Anling Hu
Eldad Zacksenhaus
Eldad Zacksenhaus
Yanmei Li
Yanmei Li
Xiaojiang Hao
Xiaojiang Hao
Yaacov Ben-David
Yaacov Ben-David
author_facet Chunlin Wang
Chunlin Wang
Klarke M. Sample
Babu Gajendran
Babu Gajendran
Philipp Kapranov
Wuling Liu
Wuling Liu
Anling Hu
Anling Hu
Eldad Zacksenhaus
Eldad Zacksenhaus
Yanmei Li
Yanmei Li
Xiaojiang Hao
Xiaojiang Hao
Yaacov Ben-David
Yaacov Ben-David
author_sort Chunlin Wang
collection DOAJ
description Wiskott–Aldrich Syndrome, WAS/WAVE, is a rare, X-linked immune-deficiency disease caused by mutations in the WAS gene, which together with its homolog, N-WASP, regulates actin cytoskeleton remodeling and cell motility. WAS patients suffer from microthrombocytopenia, characterized by a diminished number and size of platelets, though the underlying mechanism is not fully understood. Here, we identified FLI1 as a direct transcriptional regulator of WAS and its binding partner WIP. Depletion of either WAS or WIP in human erythroleukemic cells accelerated cell proliferation, suggesting tumor suppressor function of both genes in leukemia. Depletion of WAS/WIP also led to a significant reduction in the percentage of CD41 and CD61 positive cells, which mark committed megakaryocytes. RNAseq analysis revealed common changes in megakaryocytic gene expression following FLI1 or WASP knockdown. However, in contrast to FLI1, WASP depletion did not alter expression of late-stage platelet-inducing genes. N-WASP was not regulated by FLI1, yet its silencing also reduced the percentage of CD41+ and CD61+ megakaryocytes. Moreover, combined knockdown of WASP and N-WASP further suppressed megakaryocyte differentiation, indicating a major cooperation of these related genes in controlling megakaryocytic cell fate. However, unlike WASP/WIP, N-WASP loss suppressed leukemic cell proliferation. WASP, WIP and N-WASP depletion led to induction of FLI1 expression, mediated by GATA1, and this may mitigate the severity of platelet deficiency in WAS patients. Together, these results uncover a crucial role for FLI1 in megakaryocyte differentiation, implicating this transcription factor in regulating microthrombocytopenia associated with Wiskott–Aldrich syndrome.
first_indexed 2024-12-20T02:51:37Z
format Article
id doaj.art-a925b2552a9c471eb1e7e8e64a1d2c17
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T02:51:37Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-a925b2552a9c471eb1e7e8e64a1d2c172022-12-21T19:56:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-02-011210.3389/fimmu.2021.607836607836FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich SyndromeChunlin Wang0Chunlin Wang1Klarke M. Sample2Babu Gajendran3Babu Gajendran4Philipp Kapranov5Wuling Liu6Wuling Liu7Anling Hu8Anling Hu9Eldad Zacksenhaus10Eldad Zacksenhaus11Yanmei Li12Yanmei Li13Xiaojiang Hao14Xiaojiang Hao15Yaacov Ben-David16Yaacov Ben-David17State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, ChinaThe Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, ChinaThe National Health Commission’s Key Laboratory of Immunological Pulmonary Disease, Guizhou Provincial People’s Hospital, The Affiliated Hospital of Guizhou University, Guiyang, ChinaState Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, ChinaThe Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, ChinaSchool of Biomedical Sciences, Institute of Genomics, Huaqiao University, Xiamen, ChinaState Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, ChinaThe Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, ChinaState Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, ChinaThe Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, ChinaDepartment of Medicine, University of Toronto, Toronto, ON, CanadaDivision of Advanced Diagnostics, Toronto General Research Institute—University Health Network, Toronto, ON, CanadaState Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, ChinaThe Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, ChinaState Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, ChinaThe Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, ChinaState Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, ChinaThe Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, ChinaWiskott–Aldrich Syndrome, WAS/WAVE, is a rare, X-linked immune-deficiency disease caused by mutations in the WAS gene, which together with its homolog, N-WASP, regulates actin cytoskeleton remodeling and cell motility. WAS patients suffer from microthrombocytopenia, characterized by a diminished number and size of platelets, though the underlying mechanism is not fully understood. Here, we identified FLI1 as a direct transcriptional regulator of WAS and its binding partner WIP. Depletion of either WAS or WIP in human erythroleukemic cells accelerated cell proliferation, suggesting tumor suppressor function of both genes in leukemia. Depletion of WAS/WIP also led to a significant reduction in the percentage of CD41 and CD61 positive cells, which mark committed megakaryocytes. RNAseq analysis revealed common changes in megakaryocytic gene expression following FLI1 or WASP knockdown. However, in contrast to FLI1, WASP depletion did not alter expression of late-stage platelet-inducing genes. N-WASP was not regulated by FLI1, yet its silencing also reduced the percentage of CD41+ and CD61+ megakaryocytes. Moreover, combined knockdown of WASP and N-WASP further suppressed megakaryocyte differentiation, indicating a major cooperation of these related genes in controlling megakaryocytic cell fate. However, unlike WASP/WIP, N-WASP loss suppressed leukemic cell proliferation. WASP, WIP and N-WASP depletion led to induction of FLI1 expression, mediated by GATA1, and this may mitigate the severity of platelet deficiency in WAS patients. Together, these results uncover a crucial role for FLI1 in megakaryocyte differentiation, implicating this transcription factor in regulating microthrombocytopenia associated with Wiskott–Aldrich syndrome.https://www.frontiersin.org/articles/10.3389/fimmu.2021.607836/fullWiskott–Aldrich SyndromemegakaryopoiesismicrothrombocytopeniaFLI1immunodeficiencyWASP
spellingShingle Chunlin Wang
Chunlin Wang
Klarke M. Sample
Babu Gajendran
Babu Gajendran
Philipp Kapranov
Wuling Liu
Wuling Liu
Anling Hu
Anling Hu
Eldad Zacksenhaus
Eldad Zacksenhaus
Yanmei Li
Yanmei Li
Xiaojiang Hao
Xiaojiang Hao
Yaacov Ben-David
Yaacov Ben-David
FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
Frontiers in Immunology
Wiskott–Aldrich Syndrome
megakaryopoiesis
microthrombocytopenia
FLI1
immunodeficiency
WASP
title FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
title_full FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
title_fullStr FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
title_full_unstemmed FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
title_short FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
title_sort fli1 induces megakaryopoiesis gene expression through was wip dependent and independent mechanisms implications for wiskott aldrich syndrome
topic Wiskott–Aldrich Syndrome
megakaryopoiesis
microthrombocytopenia
FLI1
immunodeficiency
WASP
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.607836/full
work_keys_str_mv AT chunlinwang fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT chunlinwang fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT klarkemsample fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT babugajendran fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT babugajendran fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT philippkapranov fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT wulingliu fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT wulingliu fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT anlinghu fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT anlinghu fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT eldadzacksenhaus fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT eldadzacksenhaus fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT yanmeili fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT yanmeili fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT xiaojianghao fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT xiaojianghao fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT yaacovbendavid fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome
AT yaacovbendavid fli1inducesmegakaryopoiesisgeneexpressionthroughwaswipdependentandindependentmechanismsimplicationsforwiskottaldrichsyndrome